SEC Form 4 · accession 0001127602-17-027049
Elevance Health, Inc. · ELV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacquelyn H Wolf
Officer — EVP & Chief HR Officer
Period of report
Sep 1, 2017
Accepted (ET)
Sep 6, 2017 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156039
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2017 | A | 950 | $0.00 | A | 950 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $197.43 | Sep 1, 2017 | A | 3,882 | A | — | Sep 1, 2027 | Common Stock | 3,882 | 3,882 | D |
Explanation of responses
- F1Represents restricted share units. Restrictions lapse as follows: 316 shares on 9/1/2018, and 317 shares each on 9/1/2019 and 9/1/2020.
- F2The option represents a right to purchase a total of 3,882 shares, and is exercisable in six semi-annual installments of 647 shares each, beginning on March 1, 2018, which is the six-month anniversary of the option grant date.